Supreme Court: Breach of Contract is Not Cheating Unless Fraud Existed From the Outset || Supreme Court: Specific Performance of an Agreement to Sell May be Denied After a Long Delay || Supreme Court: Section 498A IPC Applies to Live-In Relationships in Nature of Marriage || Supreme Court Awards Rs.83.38 Lakh to Child Left Paralysed, Stressing Impact on the Victim’s Future || J&K and Ladakh High Court: Private Trust Cannot Oppose Wakf Takeover Without Legal Authority || P&H HC: Courts Cannot Grant Protection to a Minor’s Live-In Relationship Prohibited By Law || Chhattisgarh High Court: NEET OMR Tampering Allegations Cannot Rest on Mere Suspicion || Allahabad High Court Upholds Conviction, Says a Reliable Dying Declaration Alone Can Sustain Guilt || Bombay HC Criticises ITAT for Delays in Pronouncing Orders Beyond 90-Day Limit || P&H High Court Criticises Punjab For Spending on Freebies and Ads While Delaying Employee Dues

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :